Open the mobile version, with barcode scanning
Class I Ongoing

Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLE…

Why: Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Company
American Regent, Inc.
Shirley, NY, United States
Reported
Aug 26, 2026
Recall started
Jul 24, 2026
Where sold
Nationwide within the U.S
Amount
86,100 vials
Full product description
Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.
Lots / codes affected
Lot #: 25202, Exp. Date: 11/30/2026.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.